Prostate ablation is a group of minimally invasive procedures that destroy targeted prostate tissue using energy sources like heat, cold, or electrical pulses. It’s used to treat two main conditions: benign prostatic hyperplasia (BPH), where an enlarged prostate blocks urine flow, and localized prostate cancer, where the goal is to eliminate tumors while sparing surrounding healthy tissue. Unlike traditional surgery, which removes part or all of the prostate, ablation destroys tissue in place and lets the body gradually absorb it over the following weeks.
How Ablation Destroys Prostate Tissue
All prostate ablation techniques share the same basic principle: deliver enough energy to a targeted area to kill cells without cutting them out. The specific mechanism varies by technique, but the result is the same. Cells in the treatment zone die, the body’s immune system clears the debris, and the tissue shrinks. For BPH, this relieves pressure on the urethra so urine flows more freely. For cancer, it eliminates the tumor while preserving as much healthy prostate as possible.
What makes ablation appealing is precision. Depending on the method, the destruction zone can be controlled down to millimeters, with a boundary as narrow as 50 micrometers between treated and untreated tissue. That level of control is what allows these procedures to spare nearby nerves and structures that affect urinary and sexual function.
Types of Prostate Ablation
Water Vapor Therapy (Steam)
Water vapor ablation injects steam directly into the obstructing prostate tissue through a small device inserted via the urethra. The steam, heated to about 217°F (103°C), disperses evenly through the tissue. When it contacts cell membranes, it condenses back into liquid and releases its thermal energy, raising tissue temperatures to 158 to 176°F (70 to 80°C). That causes immediate cell death and creates a roughly spherical lesion in the targeted area. This technique is primarily used for BPH rather than cancer.
High-Intensity Focused Ultrasound (HIFU)
HIFU concentrates ultrasound waves into a tight focal point inside the prostate, generating intense localized heat. The resulting destruction zone is extremely precise, roughly 1 millimeter in diameter and 1 centimeter in length per treatment spot. The device is typically inserted through the rectum and aimed using imaging guidance. HIFU is primarily used for localized prostate cancer, allowing doctors to target tumors while leaving healthy tissue intact just fractions of a millimeter away.
Cryoablation (Freezing)
Cryoablation works in the opposite direction, using extreme cold to kill tissue. Thin needle-like probes are inserted through the skin between the scrotum and rectum, then guided into the prostate. The probes rapidly cool the tissue to below negative 40°C, a threshold at which nearly all cell types die. The procedure uses repeated freeze-thaw cycles because alternating between freezing and slow passive thawing causes significantly more tissue destruction than a single freeze. Cryoablation is used for both localized prostate cancer and recurrent cancer after radiation therapy.
MRI-Guided Transurethral Ultrasound Ablation (TULSA)
TULSA is a newer approach that combines ultrasound energy with real-time MRI monitoring. A catheter-like device containing 10 ultrasound transducers is placed through the urethra. While the patient lies inside an MRI scanner, the device delivers focused ultrasound energy that heats targeted tissue above 55°C. What sets TULSA apart is the continuous MRI thermometry, which lets the treatment team watch temperature changes in real time and adjust the energy delivery during the procedure. A multicenter study of 115 men with mostly intermediate-risk prostate cancer demonstrated this approach for whole-gland treatment.
Irreversible Electroporation (NanoKnife)
Unlike every other ablation method, irreversible electroporation doesn’t use temperature at all. Instead, needle electrodes inserted into the prostate deliver rapid electrical pulses that create permanent nanoscale holes in cell membranes. Once enough pores form, cells can no longer maintain their internal environment and die. Because this mechanism is non-thermal, it can be used safely near major blood vessels and nerves without damaging them. The electric field strength, pulse duration, and electrode spacing determine exactly where cell death occurs.
What Ablation Treats
For BPH, ablation relieves the physical compression of the urethra caused by overgrown prostate tissue. Symptoms like weak urine stream, frequent nighttime urination, and difficulty emptying the bladder improve as the treated tissue shrinks over several weeks.
For prostate cancer, ablation is typically offered to men with localized, low-to-intermediate-risk disease. In clinical trials, candidates have generally had tumors confined to the prostate (stage T1 to T2c) with PSA levels at or below 10 ng/mL and lower Gleason scores. The approach is sometimes called “focal therapy” because it targets only the tumor and a margin of surrounding tissue rather than the entire gland. It’s also used as a salvage treatment when cancer returns after radiation.
Outcomes and Recurrence
A study following 30 men for a median of about six years after focal laser ablation found that 83% remained free from needing whole-gland treatment, systemic therapy, or developing metastasis. No patients in the cohort died from prostate cancer. However, recurrence in or near the treated area was common: 40% of those who avoided whole-gland treatment developed local recurrence, and most of those underwent a second round of targeted ablation using techniques like cryotherapy or HIFU.
This pattern reflects both the strength and limitation of focal ablation for cancer. It preserves quality of life by avoiding radical surgery, but it requires ongoing monitoring with MRI and biopsies, and some men will need additional treatment over time. The tradeoff is generally favorable for men with low-to-intermediate-risk cancer who want to avoid or delay the side effects of more aggressive approaches.
Recovery After Prostate Ablation
Recovery from ablation procedures is substantially faster than from traditional prostate surgery. Most ablation techniques are outpatient or require only a short hospital stay. A temporary urinary catheter is typically placed after the procedure to allow swelling to subside, though the duration varies by technique. Water vapor therapy patients often have a catheter for just a few days, while other methods may require slightly longer.
For comparison, robotic prostatectomy (complete surgical removal) requires a catheter for six to nine days, limits driving for two weeks, and restricts heavy exercise for three to four weeks while incisions heal. Ablation avoids external incisions entirely, so physical recovery is generally quicker. Most men return to light daily activities within a day or two. The full effect of ablation on symptoms, whether for BPH or cancer, develops gradually as treated tissue breaks down over weeks to months.
Side Effects Compared to Surgery
The main reason men choose ablation over radical prostatectomy is the lower risk of two significant complications: urinary incontinence and erectile dysfunction. Radical surgery requires cutting the prostate free from surrounding structures, which can damage the nerves and muscles responsible for both functions. Ablation, by targeting only specific tissue within or around the prostate, leaves most of these structures intact.
Side effects still occur with ablation but tend to be milder and more often temporary. Short-term urinary symptoms like burning, frequency, or urgency are common in the days to weeks after any prostate ablation. Some men experience blood in the urine or semen. The risk of lasting erectile dysfunction or incontinence depends on the specific technique, the amount of tissue treated, and how close the treatment zone is to critical nerve bundles. Whole-gland ablation carries higher risks of these side effects than focal (partial) ablation, though both carry lower rates than complete surgical removal.